First Time Loading...

Lonza Group AG
SIX:LONN

Watchlist Manager
Lonza Group AG Logo
Lonza Group AG
SIX:LONN
Watchlist
Price: 581 CHF 3.79% Market Closed
Updated: Jul 27, 2024
Have any thoughts about
Lonza Group AG?
Write Note

Intrinsic Value

Lonza Group AG engages in the supply of pharmaceutical, healthcare and life science products. [ Read More ]

The intrinsic value of one LONN stock under the Base Case scenario is 564.14 CHF. Compared to the current market price of 581 CHF, Lonza Group AG is Overvalued by 3%.

Key Points:
LONN Intrinsic Value
Base Case
564.14 CHF
Overvaluation 3%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Lonza Group AG

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling LONN stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Lonza's Steady Outlook Amid Q1 Softness and Future Growth Plans
Earnings Call Summary

Lonza's Steady Outlook Amid Q1 Softness and Future Growth Plans

Lonza reported softer performance in Q1 2024 due to batch timing and weaker demand in some divisions. However, they maintain confidence in their full-year outlook with a flat constant currency revenue growth and CORE EBITDA margins between 27% and 29%. Strong commercial demand in Biologics and significant future growth from the Roche agreement are expected to drive H2 improvements. Ongoing projects, including new facilities in Switzerland, indicate progress. The company also advanced its share buyback program and confirmed Wolfgang Wienand as the new CEO starting in summer 2024.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Lonza Group AG

Current Assets 4.9B
Cash & Short-Term Investments 1.7B
Receivables 1.2B
Other Current Assets 2.1B
Non-Current Assets 11.9B
PP&E 6.6B
Intangibles 4.7B
Other Non-Current Assets 589m
Current Liabilities 2.8B
Accounts Payable 468m
Other Current Liabilities 2.3B
Non-Current Liabilities 4.6B
Long-Term Debt 2.6B
Other Non-Current Liabilities 2B
Efficiency

Earnings Waterfall
Lonza Group AG

Revenue
6.7B CHF
Cost of Revenue
-4.3B CHF
Gross Profit
2.4B CHF
Operating Expenses
-1.1B CHF
Operating Income
1.3B CHF
Other Expenses
-677m CHF
Net Income
654m CHF

Free Cash Flow Analysis
Lonza Group AG

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

LONN Profitability Score
Profitability Due Diligence

Lonza Group AG's profitability score is 54/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Net Income
Positive 3-Year Average ROE
Positive 3-Years Revenue Growth
54/100
Profitability
Score

Lonza Group AG's profitability score is 54/100. The higher the profitability score, the more profitable the company is.

LONN Solvency Score
Solvency Due Diligence

Lonza Group AG's solvency score is 72/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
Low D/E
High Altman Z-Score
Long-Term Solvency
72/100
Solvency
Score

Lonza Group AG's solvency score is 72/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

LONN Price Targets Summary
Lonza Group AG

Wall Street analysts forecast LONN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for LONN is 593.4 CHF with a low forecast of 328.25 CHF and a high forecast of 699.3 CHF.

Lowest
Price Target
328.25 CHF
44% Downside
Average
Price Target
593.4 CHF
2% Upside
Highest
Price Target
699.3 CHF
20% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for LONN?

Click here to dive deeper.

Competitive Landscape

Price Appreciation

LONN Price
Lonza Group AG

1M 1M
+19%
6M 6M
+34%
1Y 1Y
+16%
3Y 3Y
-14%
5Y 5Y
+71%
10Y 10Y
+566%
Annual Price Range
581
52w Low
311.5
52w High
581
Price Metrics
Average Annual Return 14.46%
Standard Deviation of Annual Returns 42.18%
Max Drawdown -60%
Shares Statistics
Market Capitalization 41.8B CHF
Shares Outstanding 72 116 600
Percentage of Shares Shorted
N/A

LONN Return Decomposition
Main factors of price return

What is price return decomposition?

LONN News

Other Videos

Company Profile

Lonza Group AG Logo
Lonza Group AG

Country

Switzerland

Industry

Life Sciences Tools & Services

Market Cap

41.8B CHF

Dividend Yield

0%

Description

Lonza Group AG engages in the supply of pharmaceutical, healthcare and life science products. The company is headquartered in Basel, Basel-Stadt and currently employs 16,218 full-time employees. The company went IPO on 2002-04-03. The firm's offerings include custom development and manufacturing of drugs and drug delivery systems, as well as development of anti-microbial solutions for commercial applications. The firm divides its activities into two segments: Pharma&Biotech and Specialty Ingredients. The Pharma&Biotech comprises the Company's Biologics, Small-Molecule, and Consumables and Research Tools businesses. The segment includes mammalian, microbial, chemical, bioconjugates, cell and gene therapy technology platforms. The Specialty Ingredients segment focuses on anti-microbial applications within Consumer Health division, which covers hygiene, nutrition and personal care products, as well as preservatives, capsules and food supplements, among others, and Consumer & Resources Protection division, which includes coatings and composites, and agro ingredients.

Contact

BASEL-STADT
Basel
Muenchensteinerstrasse 38
+41613168111.0
https://www.lonza.com/

IPO

2002-04-03

Employees

16 218

Officers

Interim CEO & Chairman
Mr. Albert M. Baehny
Chief Financial Officer
Mr. Philippe Deecke
Head of Group Operations
Ms. Maria Soler Nunez
Vice President of Investor Relations
Mr. Dirk Oehlers
Group General Counsel & Company Secretary
Mr. Andreas Bohrer
Head of Ethics & Compliance, ERM and Corporate Responsibility
Ms. Kim Harrelson
Show More
Head of External Communications
Ms. Victoria Morgan
Senior Director of Global Marketing
Ms. Jennifer Clancy
Chief Human Resources Officer
Ulrike Kaeppler
Head of Corporate Environment, Health, Safety & Global Sustainability
Dr. Matthias Hofmann
Show Less

See Also

Discover More
What is the Intrinsic Value of one LONN stock?

The intrinsic value of one LONN stock under the Base Case scenario is 564.14 CHF.

Is LONN stock undervalued or overvalued?

Compared to the current market price of 581 CHF, Lonza Group AG is Overvalued by 3%.